0.5978 USD
-0.07 (-10.12%)
Last: Jan 30, 2026, 08:07 PM
ChartMill assigns a Buy % Consensus number of 46% to MTNB. The Buy consensus is the weighted average rating of the current analysts ratings.
- MTNB was analyzed by 7 analysts. The buy percentage consensus is at 46. So analysts seem to be rather neutral about MTNB.
- In the previous month the buy percentage consensus was at a similar level.
- MTNB was analyzed by 7 analysts. More opinions would make the average more meaningful.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-10-31 | Maxim Group | Downgrade | Buy -> Hold |
| 2023-10-11 | BTIG | Reiterate | Buy -> Buy |
| 2023-01-31 | HC Wainwright & Co. | Reiterate | Buy |
MATINAS BIOPHARMA HOLDINGS I / MTNB FAQ
How do analysts rate MATINAS BIOPHARMA HOLDINGS I (MTNB)?
The consensus rating for MATINAS BIOPHARMA HOLDINGS I (MTNB) is 45.7143 / 100 . This indicates that analysts generally have a neutral outlook on the stock.
How many analysts have analysed MATINAS BIOPHARMA HOLDINGS I (MTNB)?
The number of analysts covering MATINAS BIOPHARMA HOLDINGS I (MTNB) is 7.